Rx Only Drops (eye / ear / nasal) • Beta-adrenergic antagonist; antiglaucoma
✓ Medically Reviewed Monograph

Timolol

Also known as / Synonyms: Timolol Maleate, Non-Selective Beta-Blocker

Beta-blocker eye drops that reduce aqueous humor production to lower elevated eye pressure in glaucoma.

🩺
Reviewed by Dr. Lisa M., PharmD
Chief Clinical Editor · Updated November 18, 2026 · Editorial & Fact-Checking Policy
CDSCO & FDA Aligned
📋

Clinical Snapshot & Specifications

Generic Name: Timolol
Active Ingredient: Timolol Maleate
Dosage Form: Drops (eye / ear / nasal)
Available Strengths: 0.25% w/v, 0.5% w/v ophthalmic solution (eye drops); 5 mg, 10 mg oral tablets
Prescription Status: Prescription only (Schedule H / verified)
Approved Routes:
Ophthalmic (eye) Oral
Popular Verified Brands:
Glucomol Timoptic Timolet Istalol (India)
Regulatory Standards: Approved by CDSCO; Schedule H prescription drug in India. Gold standard beta-blocker on the WHO List of Essential Medicines.
🎯

Approved Indications & Medical Uses

  • Reduction of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
  • Oral formulations: treatment of systemic hypertension, long-term prophylaxis after myocardial infarction, and migraine prophylaxis.
🚫

Contraindications (Do Not Use If…)

  • Bronchial asthma or history of severe chronic obstructive pulmonary disease (COPD).
  • Sinus bradycardia (heart rate < 50-60 bpm).
  • Second or third-degree atrioventricular (AV) block.
  • Overt cardiac failure or cardiogenic shock.
  • Known hypersensitivity to timolol maleate.
🛡️

Important Clinical Precautions & Warnings

  • Systemic absorption from eye drops: topical ophthalmic beta-blockers undergo systemic absorption via nasolacrimal drainage, producing systemic cardiovascular and pulmonary beta-blockade; perform nasolacrimal occlusion (press inner corner of eye for 2 minutes after instillation).
  • Severe bronchospasm in asthma: can cause fatal status asthmaticus even from eye drops; strictly contraindicated in asthmatic patients.
  • Cardiac failure and bradycardia: monitor pulse and blood pressure; discontinue at first sign of cardiac decompensation.
  • Hypoglycemia masking: can mask early warning signs of acute hypoglycemia (tachycardia, palpitations) in diabetic patients.
  • Choroidal detachment: reported after filtration procedures with administration of aqueous suppressant therapy.

Special Populations (Paediatric & Geriatric Care)

Pediatric: Safety and efficacy have been demonstrated in pediatric patients, but monitor closely for apnea and bradycardia. Geriatric: No overall differences in efficacy; elderly patients are more prone to systemic cardiovascular side effects.

⚡

Side Effects & Adverse Reactions

ℹ️ Common Side Effects (Usually Mild)

Transient eye burning, stinging, itching, blurred vision, conjunctival hyperemia, foreign body sensation, headache, and mild bradycardia.

🚨 Serious Side Effects — Seek Urgent Medical Care

Severe bronchospasm and fatal status asthmaticus, severe bradycardia, heart block, heart failure decompensation, syncope, and anaphylaxis.

Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.

🔄

Drug, Food & Substance Interactions

  • Systemic beta-blockers: additive effects on systemic beta-blockade, heart rate, and intraocular pressure; monitor patients taking both.
  • Calcium channel blockers (verapamil, diltiazem): heightened risk of bradycardia, hypotension, and AV conduction block.
  • Digitalis glycosides: co-administration increases AV conduction delay and bradycardia risk.
  • CYP2D6 inhibitors (quinidine, fluoxetine): inhibit timolol metabolism, significantly increasing systemic timolol levels and systemic beta-blocker side effects.
🤰

Pregnancy & Lactation Clinical Safety

Pregnancy Safety:

Use with caution — see notes

Timolol passes into the systemic circulation and crosses the placenta. Topical use during pregnancy should be considered only if the potential benefit justifies potential fetal risk. If used near term, monitor neonate for bradycardia and hypoglycemia.

Lactation & Breastfeeding:

Timolol is excreted in human breast milk. With topical ophthalmic drops, systemic maternal levels are minimal, and infant exposure is clinically negligible when nasolacrimal occlusion is performed. Considered compatible with breastfeeding.

📦

Storage, Administration & Overdose Protocol

🌡️ Recommended Storage:

Store eye drops at 15°C to 25°C (59°F to 77°F). Protect from light. Keep bottle tightly closed. Discontinue 4 weeks after opening.

⏱️ Missed Dose Protocol:

Instill the missed eye drop as soon as remembered. If close to the next scheduled dose, skip and resume regular routine. Do not instill two drops at the same time.

🛡️
Clinical & Legal Disclaimer: The clinical monographs and drug information published on 4mg.in are strictly intended for educational, clinical reference, and informational utility. They do not constitute personalized medical advice, diagnosis, or treatment regimens. Always seek the advice of a registered physician or licensed pharmacist regarding specific clinical conditions, prescription dosages, and potential contraindications. Review our comprehensive Editorial & Clinical Fact-Checking Policy.